FindTrial
Sign In

KAP Study on the Application of Anti-influenza Drugs (Baloxavir Marboxil/Oseltamivir/Peramivir) in Children by Healthcare Professionals/Parents

KAP Study on the Application of Anti-influenza Drugs (Baloxavir Marboxil/Oseltamivir/Peramivir) in Children by Healthcare Professionals/Parents

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126452
Enrollment
Unknown
Registered
2026-06-09
Start date
2025-05-03
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza

Interventions

Healthcare professionals group:None
Guardians group:None

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Medical staff of our hospital and parents of children who have been treated in our hospital and have used Marboxilavir/Oseltamivir/Peramivir

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
knowledge-attitudes-practices score;—

Secondary

MeasureTime frame
Demographic Data;—

Countries

China

Contacts

Public ContactJingrui Liu

The Affiliated Hospital of Xuzhou Medical University

271881715@qq.com+86 138 1346 1710

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026